160 Participants NeededMy employer runs this trial

Home Urine Testing for Lupus

PI
JB
Overseen ByJill Buyon, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Study participants enrolled in the SAMPLE Biorepository (s14-00487) who have provided permission to be contacted for future research will be enrolled and randomized (1:1) two-arm controlled) to either 1) perform weekly home-based proteinuria testing in addition to standard of care or 2) standard of care only. Participants randomized to the home-based proteinuria testing arm will perform weekly home-based proteinuria testing in addition to having standard of care and respond to study team's weekly text messages with urine test results for one year.

Who Is on the Research Team?

PI

Peter Izmirly, MD

Principal Investigator

NYU Langone Health

Are You a Good Fit for This Trial?

This trial is for people with lupus who are already part of the SAMPLE Biorepository and have agreed to be contacted for future research. Participants must be able to perform home urine tests and communicate results by text message.

Inclusion Criteria

Willing to provide informed consent
Must be enrolled in SAMPLE Biorepository (s14-00487)
Ownership of any mobile phone
See 4 more

Exclusion Criteria

I am able and willing to participate and understand the consent form in English, Spanish, or Mandarin.
Does not own a mobile phone
Not enrolled in SAMPLE Biorepository (s14-00487)

What Are the Treatments Tested in This Trial?

Interventions

  • Home Urine Testing

Trial Overview

The study compares weekly at-home urine protein testing plus usual care versus usual care alone in people with lupus. Participants are randomly assigned to one of these two groups, and those doing home testing send their results by text each week for a year.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Weekly Home-Based Proteinuria TestingExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

Centers for Disease Control and Prevention

Collaborator

Trials
902
Recruited
25,020,000+